EG23853A - Antiviral glucocorticoid formulation comprising propylene glycol and ispropyl alkanoic acid esters - Google Patents
Antiviral glucocorticoid formulation comprising propylene glycol and ispropyl alkanoic acid estersInfo
- Publication number
- EG23853A EG23853A EG146899A EG146899A EG23853A EG 23853 A EG23853 A EG 23853A EG 146899 A EG146899 A EG 146899A EG 146899 A EG146899 A EG 146899A EG 23853 A EG23853 A EG 23853A
- Authority
- EG
- Egypt
- Prior art keywords
- ispropyl
- antiviral
- propylene glycol
- acid esters
- alkanoic acid
- Prior art date
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 title 3
- 239000002253 acid Substances 0.000 title 1
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000003862 glucocorticoid Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803929A SE9803929D0 (sv) | 1998-11-18 | 1998-11-18 | Antiviral formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG23853A true EG23853A (en) | 2007-11-06 |
Family
ID=20413320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG146899A EG23853A (en) | 1998-11-18 | 1999-11-16 | Antiviral glucocorticoid formulation comprising propylene glycol and ispropyl alkanoic acid esters |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1131104B1 (OSRAM) |
| JP (2) | JP2002529520A (OSRAM) |
| KR (1) | KR100608963B1 (OSRAM) |
| CN (1) | CN1160128C (OSRAM) |
| AR (1) | AR023705A1 (OSRAM) |
| AT (1) | ATE288283T1 (OSRAM) |
| AU (1) | AU772435B2 (OSRAM) |
| CA (1) | CA2351463C (OSRAM) |
| DE (1) | DE69923584T2 (OSRAM) |
| DK (1) | DK1131104T3 (OSRAM) |
| EG (1) | EG23853A (OSRAM) |
| ES (1) | ES2233104T3 (OSRAM) |
| HK (1) | HK1042440B (OSRAM) |
| IL (2) | IL142702A0 (OSRAM) |
| MY (1) | MY122397A (OSRAM) |
| NZ (1) | NZ511832A (OSRAM) |
| PT (1) | PT1131104E (OSRAM) |
| SE (1) | SE9803929D0 (OSRAM) |
| TW (1) | TW589191B (OSRAM) |
| WO (1) | WO2000029027A1 (OSRAM) |
| ZA (1) | ZA200103335B (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7858662B2 (en) | 2001-11-19 | 2010-12-28 | Medigene Ag | Medicament for the treatment of viral skin and tumour diseases |
| BRPI0415215B8 (pt) | 2003-10-09 | 2021-05-25 | Medigene Ag | uso de polifenol na preparação de medicamento |
| JP4972062B2 (ja) * | 2008-03-17 | 2012-07-11 | メディヴィル・アクチエボラーグ | 抗ウイルス製剤 |
| WO2020036545A1 (en) * | 2018-08-17 | 2020-02-20 | İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Phase stable topical composition comprising acyclovir and hydrocortisone |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ1966A1 (fr) * | 1995-02-06 | 2002-10-15 | Astra Ab | Combinaison pharmaceutique nouvelle. |
| US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
-
1998
- 1998-11-18 SE SE9803929A patent/SE9803929D0/xx unknown
-
1999
- 1999-11-12 AU AU14364/00A patent/AU772435B2/en not_active Expired
- 1999-11-12 PT PT99972109T patent/PT1131104E/pt unknown
- 1999-11-12 DK DK99972109T patent/DK1131104T3/da active
- 1999-11-12 JP JP2000582073A patent/JP2002529520A/ja active Pending
- 1999-11-12 HK HK02104279.2A patent/HK1042440B/zh not_active IP Right Cessation
- 1999-11-12 KR KR1020017006232A patent/KR100608963B1/ko not_active Expired - Fee Related
- 1999-11-12 DE DE69923584T patent/DE69923584T2/de not_active Expired - Lifetime
- 1999-11-12 IL IL14270299A patent/IL142702A0/xx active IP Right Grant
- 1999-11-12 CN CNB998133825A patent/CN1160128C/zh not_active Expired - Lifetime
- 1999-11-12 ES ES99972109T patent/ES2233104T3/es not_active Expired - Lifetime
- 1999-11-12 CA CA002351463A patent/CA2351463C/en not_active Expired - Lifetime
- 1999-11-12 AT AT99972109T patent/ATE288283T1/de active
- 1999-11-12 NZ NZ511832A patent/NZ511832A/en not_active IP Right Cessation
- 1999-11-12 WO PCT/SE1999/002043 patent/WO2000029027A1/en not_active Ceased
- 1999-11-12 EP EP99972109A patent/EP1131104B1/en not_active Expired - Lifetime
- 1999-11-15 TW TW088119865A patent/TW589191B/zh not_active IP Right Cessation
- 1999-11-16 MY MYPI99004979A patent/MY122397A/en unknown
- 1999-11-16 EG EG146899A patent/EG23853A/xx active
- 1999-11-17 AR ARP990105846A patent/AR023705A1/es active IP Right Grant
-
2001
- 2001-04-19 IL IL142702A patent/IL142702A/en not_active IP Right Cessation
- 2001-04-24 ZA ZA200103335A patent/ZA200103335B/en unknown
-
2011
- 2011-04-11 JP JP2011087438A patent/JP5420583B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE288283T1 (de) | 2005-02-15 |
| NZ511832A (en) | 2003-09-26 |
| PT1131104E (pt) | 2005-03-31 |
| ZA200103335B (en) | 2002-07-24 |
| IL142702A0 (en) | 2002-03-10 |
| DE69923584T2 (de) | 2006-03-23 |
| AU1436400A (en) | 2000-06-05 |
| EP1131104A1 (en) | 2001-09-12 |
| JP2002529520A (ja) | 2002-09-10 |
| DK1131104T3 (da) | 2005-03-14 |
| HK1042440B (zh) | 2005-04-29 |
| KR100608963B1 (ko) | 2006-08-09 |
| IL142702A (en) | 2006-07-05 |
| JP5420583B2 (ja) | 2014-02-19 |
| SE9803929D0 (sv) | 1998-11-18 |
| CN1160128C (zh) | 2004-08-04 |
| DE69923584D1 (de) | 2005-03-10 |
| AU772435B2 (en) | 2004-04-29 |
| KR20010075720A (ko) | 2001-08-09 |
| CN1326364A (zh) | 2001-12-12 |
| JP2011157392A (ja) | 2011-08-18 |
| EP1131104B1 (en) | 2005-02-02 |
| CA2351463A1 (en) | 2000-05-25 |
| AR023705A1 (es) | 2002-09-04 |
| ES2233104T3 (es) | 2005-06-01 |
| TW589191B (en) | 2004-06-01 |
| CA2351463C (en) | 2009-10-13 |
| HK1042440A1 (en) | 2002-08-16 |
| MY122397A (en) | 2006-04-29 |
| WO2000029027A1 (en) | 2000-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG93823A1 (en) | Aryl-acrylic acid esters | |
| IL147556A0 (en) | Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents | |
| IL135177A0 (en) | Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP0101613A3 (en) | Metalloprotease inhibitor (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides and medicaments containing the same | |
| IL145732A0 (en) | α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| EP1024130A4 (en) | BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE | |
| AU7442398A (en) | Glucosamine fatty acid compositions and their use | |
| IL128600A0 (en) | Propionic acid derivatives and pharmaceutical compositions containing them | |
| IL146230A0 (en) | 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| GB9615089D0 (en) | Esters and compositions comprising them | |
| HUP0000937A3 (en) | New fatty acid derivatives | |
| HUP0001269A3 (en) | 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof | |
| DE59700915D1 (de) | Stabilisierter Milchsäurementhylester | |
| IL130150A0 (en) | Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid | |
| ITMI962505A0 (it) | Nuovi esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono | |
| HUP0100597A3 (en) | Hydroxamic and carboxylic acid derivatives | |
| AU5836498A (en) | N-acyl-hydroxyamino acid esters and their use | |
| ZA9811655B (en) | Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same | |
| EG23853A (en) | Antiviral glucocorticoid formulation comprising propylene glycol and ispropyl alkanoic acid esters | |
| IL138994A0 (en) | 2-methylpropionic acid derivatives and medicinal compositions containing the same | |
| SI1131104T1 (en) | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester | |
| GB9615086D0 (en) | Carboxylic acid esters,and compositions comprising them | |
| IL140861A0 (en) | Dioxolane derivatives and processess for the preparation of (s) -2-amino-6,6- dimethoxythexanoic acid methyl ester utilizing the same | |
| IL122919A0 (en) | Preparation of 1-alkyl-pyrazole-5-carboxylic acid esters | |
| HUP0103975A3 (en) | Phosphoric acid esters |